Role of hepatitis B antibody in predicting reactivation of resolved hepatitis B virus infection in leukemia patients.

CONCLUSION: The baseline profiles of HBV antibodies are predictive of the risk of HBVr in leukemia patients undergoing immunosuppression. However, seronegative anti-HBe is a prerequisite for using baseline anti-HBs and anti-HBc quantification to predict HBVr risk. PMID: 32171856 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32171856?dopt=Abstract

Source: Antiviral Research - March 10, 2020 Category: Virology Authors: Wu T, Wu N, Ma YX, Wu J, Gao Y, Pan XB Tags: Antiviral Res Source Type: research